Lip Neoplasms clinical trials

The registry lists 20 studies for Lip Neoplasms across 6 countries. 7 are recruiting or about to start. 4 of them are mainly about Lip Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.

Get an email when these change. Save the Lip Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 8
Recruiting: 6
Active, not recruiting: 3
Not yet recruiting: 1
Withdrawn: 1
Terminated: 1

Phase

Phase 2: 4
Phase 1: 2
Phase 3: 1

Where

United States: 11
Israel: 4
Turkey: 1
Netherlands: 1
France: 1
Italy: 1

Who runs them

Alpha Tau Medical LTD. (6) · Stanford University (2) · University of Nebraska (1) · Vigilant Biosciences, Inc. (1) · Travera Inc (1) · Klus Pharma Inc. (1) · Maastricht University Medical Center (1) · UNC Lineberger Comprehensive Cancer Center (1)

What is being tested here

Drugs under test in Lip Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	All
Ficerafusp alfa	1	1
Durvalumab	0	1
Carboplatin	0	1
Albumin-Bound Paclitaxel	0	1
Paclitaxel	0	1
Ficlatuzumab	0	1
Trastuzumab botidotin	0	1

Coming up

0phase 3 studies under way

5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Nov 2026Microbiome in Head and Neck Squamous Cell Carcinoma · University of Colorado, Denver
Dec 2026Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) · Alpha Tau Medical LTD.
Jan 2027Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors · Alpha Tau Medical LTD.
Jan 2027Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia · Alpha Tau Medical LTD.
Jun 2027Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers · Stanford University

Who these studies take

Of the 6 Lip Neoplasms studies recruiting now, 4 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	0 (0%)	0 (0%)
18	5 (83%)	5 (83%)
30	6 (100%)	6 (100%)
40	6 (100%)	6 (100%)
50	6 (100%)	6 (100%)
65	6 (100%)	6 (100%)
75	6 (100%)	6 (100%)
85	6 (100%)	6 (100%)

Across all 20 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 0% take children; 0% are for women only and 0% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 20 of 20. search them.